NYSE: ABAlliancebernstein Holding LP Stock
$39.83-0.58 (-1.44%)
Updated Aug 19, 2025
AB Price
$39.83
Fair Value Price
N/A
Market Cap
$4.40B
52 Week Low
$32.28
52 Week High
$43.30
P/E
11.82x
P/B
2.22x
P/S
10.9x
PEG
2.74x
Dividend Yield
8.49%
Revenue
$414.55M
Earnings
$376.91M
Gross Margin
100%
Operating Margin
100%
Profit Margin
90.9%
Debt to Equity
0
Operating Cash Flow
$372M
Beta
0.96
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
AB Overview
AllianceBernstein Holding L.P. provides investment management and research services to high-net-worth individuals, and retail investors. The firm offers growth equities, blend strategies, fixed income, alternatives, and asset allocation. AllianceBernstein also provides investment research, trading, and brokerage-related services to institutional clients. The firm had $686B in assets under management as of 2021/04. AllianceBernstein was founded in 1987 and is headquartered in Nashville, TN.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine AB's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Asset Management
Industry Rating
C
AB
Ranked#57 of 83
Ranked#57 of 83
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $8.80 | A | |
| $47.17 | A | |
| $142.04 | B |
Be the first to know about important AB news, forecast changes, insider trades & much more!
AB News
Overview
Due Diligence Score
–
Industry Average (32)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how AB scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
AB ($39.83) is trading above its intrinsic value of $24.34, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
AB is good value based on its earnings relative to its share price (11.82x), compared to the US market average (35.19x)
P/E vs Market Valuation
AB is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more AB due diligence checks available for Premium users.
Valuation
AB price to earnings (PE)
For valuing profitable companies with steady earnings
Company
11.82x
Industry
47.76x
Market
35.19x
AB is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
AB is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
AB price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.22x
Industry
3.03x
AB is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
AB price to earnings growth (PEG)
For valuing profitable companies with growth potential
AB is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
AB's financial health
Profit margin
Revenue
$78.8M
Net Income
$70.2M
Profit Margin
89.1%
AB's Earnings (EBIT) of $414.55M... subscribe to Premium to read more.
Interest Coverage Financials
AB's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$2.0B
Liabilities
$449.0k
Debt to equity
0
AB's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
AB's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$88.7M
Investing
$0.0
Financing
-$88.7M
AB's operating cash flow ($372.44M)... subscribe to Premium to read more.
Debt Coverage Financials
AB vs Asset Management Stocks
Alliancebernstein Holding Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.